Research published in The Lancet medical journal Monday showed good early results for two vaccines in the U.K. and China. The U.K. vaccine, coming out of the University of Oxford, stimulated an immune system response that built up both antibodies and T-cells, a sign of a strong vaccine candidate. Now, researchers need to determine just how effective their vaccines could be. Meanwhile, Russia is touting its own research amid allegations it's hacking other groups working toward an immunization.
2 More Vaccines Show Promise As Global Race Grows Tense
New trials will start for a Chinese vaccine; another in the U.K. had good early results. They're two of more than 200 in development across the world.
Posted at 5:46 PM, Jul 20, 2020
and last updated 2020-07-20 17:46:40-04
Copyright 2024 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
-
Viewer Spotlight: How Scripps News will continue to cover international conflicts, without opinion or spin
1:31 PM, Apr 26, 2024 -
Ex-National Enquirer publisher: Going after Trump opponents 'good for business'
12:51 PM, Apr 26, 2024 -
Report blames producers, regulators for rise in food recalls
12:25 PM, Apr 26, 2024